Editorial Team Patient Savvy Page 2

Antibody-Drug Conjugates in NSCLC: Challenges, Failures, and Breakthroughs

Non-small cell lung cancer (NSCLC) is a complex and deadly disease, but recent advances in antibody-drug conjugates (ADCs) are offering new hope for patients. ADCs combine targeted precision with powerful cancer-killing drugs, making them a promising option for treating NSCLC. However, their path to success has been challenging, with setbacks and breakthroughs shaping the therapeutic […]

Antibody-Drug Conjugates in NSCLC: Challenges, Failures, and Breakthroughs Read More »

A Pioneering Treatment Journey for Extensive-Stage SCLC

Explore how a 50-year-old extensive-stage SCLC patient achieved remarkable tumor control through a strategic blend of chemotherapy, radiotherapy, targeted therapy with anlotinib, and combination immunotherapy with durvalumab.

A Pioneering Treatment Journey for Extensive-Stage SCLC Read More »

A Remarkable Triumph Over Extensive-Stage SCLC

Discover how a 58-year-old patient with extensive-stage small cell lung cancer achieved long-lasting disease control through combination immunotherapy, careful re-challenge chemotherapy, and targeted radiation.

A Remarkable Triumph Over Extensive-Stage SCLC Read More »

From Selma to Survival: An Ongoing Triumph Over Stage IV Liver Cancer

David, now 76, recalls childhood road trips with his father’s fascination for cemeteries. Four years ago, when confronted with stage 4 liver cancer that had spread to his lung, he ordered a tombstone—only to discover that his life’s achievements were too numerous for a simple marker.

From Selma to Survival: An Ongoing Triumph Over Stage IV Liver Cancer Read More »

Beating Stage IV Liver Cancer: A Journey of Hope and Survival

Stage IV hepatic carcinoma survivor Cheryl shares her journey from an unexpected lump on her head to life-saving interventional treatments that transformed her future.

Beating Stage IV Liver Cancer: A Journey of Hope and Survival Read More »

Overcome Stage IIIC Ovarian Cancer After 2 years of Misdiagnosis

Charlotte is 31 years old. Diagnosed with ovarian cancer at 27, discovered after an intestinal obstruction, she went through numerous challenges before embarking on the most significant professional project of her life: a social and solidarity-based start-up aimed at gently supporting cancer fighters. Here is a meeting with an entrepreneur brimming with life.

Overcome Stage IIIC Ovarian Cancer After 2 years of Misdiagnosis Read More »

Embracing Life Twice Over: Triumphant Stand Against Recurrent Ovarian Cancer

“Get second or third opinions. It saved my life!” Yolanda was over nine years cancer-free when a routine check unveiled new tumors with metastases.

Embracing Life Twice Over: Triumphant Stand Against Recurrent Ovarian Cancer Read More »

Defying Stage 4 Ovarian Cancer: A Ten-Year Survival Story

Most women diagnosed with ovarian cancer will not survive five years from diagnosis. Veronica shares her story as an ovarian cancer survivor and mother.

Defying Stage 4 Ovarian Cancer: A Ten-Year Survival Story Read More »

An Inspiring Fight Against Stage III Ovarian Cancer

September is Gynaecological Cancer Awareness Month. Earlier this month, Ambassadors MP Meryl Swanson, Senator Anne Ruston, and Senator Sarah Hanson-Young hosted an Ovarian Cancer Press Gallery Networking Event, uniting media and parliament to push for greater resources. Among the guests was 44-year-old Adelaide local, Renata, who shared her powerful story of battling Stage III ovarian cancer, now in remission but still facing daunting survival odds.

An Inspiring Fight Against Stage III Ovarian Cancer Read More »

Overcoming Stage IV Ovarian Cancer with A Second Opinion

“I was given a chance to fight this cancer.” Nikki was just 42 when doctors declared her stage 4 ovarian cancer untreatable. Seeking a second opinion opened doors to life-saving treatments—now, she is one year cancer-free and able to plan for the future once more.

Overcoming Stage IV Ovarian Cancer with A Second Opinion Read More »